Filing Flows › Comparisons › CRSP vs DTIL
Crispr Therapeutics AG vs Precision Biosciences: CRSP and DTIL compared
Crispr Therapeutics AG is the larger company: $12.7M of revenue in its latest quarter (Q3 2026) against $10.8M for Precision Biosciences (Q3 FY26). Precision Biosciences is growing faster (374× against 14× a year earlier).
Where the money goes: CRSP and DTIL
Crispr Therapeutics AG (CRSP) · Q3 2026
Crispr Therapeutics AG, Q3 2026: revenue $12.7M (14× year over year), net loss $111M, operating cash flow −$89.7M. The chart follows the revenue to costs, profit and cash.
Precision Biosciences (DTIL) · Q3 FY26
Precision Biosciences, Q3 FY26: revenue $10.8M (374× year over year), operating margin -83.7%, net loss $18.4M, operating cash flow −$11.9M. The chart follows the revenue to costs, profit and cash.
| Crispr Therapeutics AG (CRSP) | Precision Biosciences (DTIL) | |
|---|---|---|
| Latest quarter | Q3 2026 | Q3 FY26 |
| Revenue | $12.7M | $10.8M |
| Revenue growth, Y/Y | 14× | 374× |
| Operating margin | n/m | -83.7% |
| Net earnings | −$111M | −$18.4M |
| Net margin | -879.6% | -170.2% |
| Operating cash flow | −$89.7M | −$11.9M |
Where the revenue comes from
Crispr Therapeutics AG
- Collaboration Revenue: $12.3M (97%)
- Grant: $346K (3%)
Questions
Which is bigger, Crispr Therapeutics AG or Precision Biosciences?
Crispr Therapeutics AG is the larger company: $12.7M of revenue in its latest quarter (Q3 2026) against $10.8M for Precision Biosciences (Q3 FY26).
Is Crispr Therapeutics AG or Precision Biosciences growing faster?
Precision Biosciences is growing faster (374× against 14× a year earlier).
More: Crispr Therapeutics AG earnings · how Crispr Therapeutics AG makes money · Precision Biosciences earnings · how Precision Biosciences makes money
From the companies' latest 10-Q, 10-K or earnings release (10-Q filed Nov 2, 2026; 10-Q filed May 5, 2026). Fiscal quarters can end on different dates. Not investment advice.